These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 1568570

  • 1. Effects of nonsteroidal anti-inflammatory drugs and misoprostol on gastroduodenal epithelial proliferation in arthritis.
    Levi S, Goodlad RA, Lee CY, Walport MJ, Wright NA, Hodgson HJ.
    Gastroenterology; 1992 May; 102(5):1605-11. PubMed ID: 1568570
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Duodenal and gastric ulcer prevention with misoprostol in arthritis patients taking NSAIDs. Misoprostol Study Group.
    Graham DY, White RH, Moreland LW, Schubert TT, Katz R, Jaszewski R, Tindall E, Triadafilopoulos G, Stromatt SC, Teoh LS.
    Ann Intern Med; 1993 Aug 15; 119(4):257-62. PubMed ID: 8328732
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prevalence of mucosal lesions in the stomach and duodenum due to chronic use of NSAID in patients with rheumatoid arthritis or osteoarthritis, and interim report on prevention by misoprostol of diclofenac associated lesions.
    Geis GS, Stead H, Wallemark CB, Nicholson PA.
    J Rheumatol Suppl; 1991 Mar 15; 28():11-4. PubMed ID: 1903808
    [Abstract] [Full Text] [Related]

  • 9. NSAID-induced gastroduodenal damage: is prevention needed? A review and metaanalysis.
    Stalnikowicz R, Rachmilewitz D.
    J Clin Gastroenterol; 1993 Oct 15; 17(3):238-43. PubMed ID: 7901267
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic nonsteroidal anti-inflammatory drug use.
    Larkai EN, Smith JL, Lidsky MD, Graham DY.
    Am J Gastroenterol; 1987 Nov 15; 82(11):1153-8. PubMed ID: 3499815
    [Abstract] [Full Text] [Related]

  • 15. Inhibitory effect of non-steroidal anti-inflammatory drugs on mucosal cell proliferation associated with gastric ulcer healing.
    Levi S, Goodlad RA, Lee CY, Stamp G, Walport MJ, Wright NA, Hodgson HJ.
    Lancet; 1990 Oct 06; 336(8719):840-3. PubMed ID: 1699093
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Treatment and prevention of NSAID induced gastroduodenal mucosal damage.
    Agrawal NM, Saggioro A.
    J Rheumatol Suppl; 1991 Mar 06; 28():15-8. PubMed ID: 1674754
    [Abstract] [Full Text] [Related]

  • 18. Diclofenac/misoprostol compared with diclofenac in the treatment of osteoarthritis of the knee or hip: a randomized, placebo controlled trial. Arthrotec Osteoarthritis Study Group.
    Bocanegra TS, Weaver AL, Tindall EA, Sikes DH, Ball JA, Wallemark CB, Geis GS, Fort JG.
    J Rheumatol; 1998 Aug 06; 25(8):1602-11. PubMed ID: 9712107
    [Abstract] [Full Text] [Related]

  • 19. Misoprostol dosage in the prevention of nonsteroidal anti-inflammatory drug-induced gastric and duodenal ulcers: a comparison of three regimens.
    Raskin JB, White RH, Jackson JE, Weaver AL, Tindall EA, Lies RB, Stanton DS.
    Ann Intern Med; 1995 Sep 01; 123(5):344-50. PubMed ID: 7625622
    [Abstract] [Full Text] [Related]

  • 20. Increased gastric juice epidermal growth factor after non-steroidal anti-inflammatory drug ingestion.
    Kelly SM, Jenner JR, Dickinson RJ, Hunter JO.
    Gut; 1994 May 01; 35(5):611-4. PubMed ID: 8200552
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.